These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38576485)

  • 1. Efficacy of traditional Chinese medicine
    Ma S; Jiang Y; Qian L; Wang M; Xu S; Wang G
    Front Pharmacol; 2024; 15():1374377. PubMed ID: 38576485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis.
    Zhao J; Ai J; Mo C; Shi W; Meng L
    Complement Ther Med; 2022 Aug; 67():102831. PubMed ID: 35398481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis.
    Zhang L; Miao R; Yu T; Wei R; Tian F; Huang Y; Tong X; Zhao L
    Pharmacol Res; 2022 Mar; 177():106111. PubMed ID: 35183713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
    Vaz de Castro PAS; Bitencourt L; Pereira BWS; Lima AQR; Hermida HS; Moreira Neto CR; Mestriner MD; Simões E Silva AC
    Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker therapy for IgA nephropathy: A meta-analysis of randomized controlled trials.
    Ji Y; Yang K; Xiao B; Lin J; Zhao Q; Bhuva MS; Yang H
    J Cell Biochem; 2019 Mar; 120(3):3689-3695. PubMed ID: 30270542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adding Rheum officinale to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal function in patients with chronic renal failure: A meta-analysis of randomized controlled trials
.
    Yang Y; Ma YP; Zhang Z; Dai PL; Li P; Li WG
    Clin Nephrol; 2018 Jun; 89(6):445-454. PubMed ID: 29208203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Renin-Angiotensin Aldosterone System Inhibitor in Patients with IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials.
    Zhao Y; Fan H; Bao BY
    Iran J Public Health; 2019 Sep; 48(9):1577-1588. PubMed ID: 31700813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis.
    Du YH; Guan CJ; Li LY; Gan P
    Ann Palliat Med; 2022 Mar; 11(3):1093-1101. PubMed ID: 35365039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
    Li P; Chen YZ; Lin HL; Ni ZH; Zhan YL; Wang R; Yang HT; Fang JA; Wang NS; Li WG; Sun XF; Chen XM
    Trials; 2017 Apr; 18(1):170. PubMed ID: 28395659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of traditional Chinese medicine decoction as an adjuvant treatment for diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials.
    Zheng S; Xu Y; Zhang Y; Long C; Chen G; Jin Z; Jiang S; Chen J; Qin Y
    Front Pharmacol; 2024; 15():1327030. PubMed ID: 38783937
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis.
    Cheng J; Zhang X; Tian J; Li Q; Chen J
    Int J Clin Pract; 2012 Oct; 66(10):917-23. PubMed ID: 22994326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: A network meta-analysis.
    Liu J; Zhang X; Xu G
    Front Pharmacol; 2022; 13():939488. PubMed ID: 36071841
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis.
    Zhu Z; Zhang Q; Liu L; Bao P; Liu S; Song C; Yang W; Nan Z
    Medicine (Baltimore); 2022 Dec; 101(49):e31490. PubMed ID: 36626537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.
    Cheng J; Zhang W; Zhang XH; He Q; Tao XJ; Chen JH
    Int J Clin Pract; 2009 Jun; 63(6):880-8. PubMed ID: 19490198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis.
    Lin YQ; Yu F; Chen HJ; Deng YR; Lin J; Xu Y; Zheng X; Zhang JW; Liu JF
    Ren Fail; 2024 Dec; 46(2):2359033. PubMed ID: 38836372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs.
    Huo Z; Ye H; Ye P; Xiao G; Zhang Z; Kong Y
    PeerJ; 2021; 9():e11661. PubMed ID: 34268008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis.
    Batty JA; Tang M; Hall M; Ferrari R; Strauss MH; Hall AS
    Syst Rev; 2018 Aug; 7(1):131. PubMed ID: 30144828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis.
    Tan Y; Zhang Z; Zhou P; Zhang Q; Li N; Yan Q; Huang L; Yu J
    Front Pharmacol; 2023; 14():1288159. PubMed ID: 38249351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.